Intelligent Bio Solutions Inc. - Common Stock INBS 深 沪
已收盘 12-19 16:00:00 美东时间
6.1475
-0.842
-12.05%
华盛通- 最 高7.252
- 今 开6.95
- 成交量 7.52万股
- 最 低 0.538
- 昨 收 6.99
- 总市值 0
- 52周最高 7.252
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.538
- 委 比 9.09%
- 总股本 --
- 历史最高 11.70
- 量 比 0.25
- 振 幅 96.05%
- 历史最低 0.17
- 每 手 1
- 风险率 0.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Intelligent Bio Solutions Announces 1-For-10 Reverse Split, Effective December 15
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("Intelligent Bio Solutions" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it
12-12 23:33
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion
Intelligent Bio Solutions Inc. (INBS) has partnered with Managed Waste Service (MWS) to implement INBS' fingerprint-based drug screening system across MWS' New South Wales operations. This marks MWS' first in-house drug testing initiative across multiple locations, enabling efficient and scalable testing solutions for safer workplaces. INBS' technology is increasingly recognized for its effectiveness and portability in critical safety industries globally.
06-18 12:30
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
INBS has partnered with SMARTOX to expand its fingerprint-based drug screening technology in the U.S. forensic market, deploying over 50 readers and completing more than 7,000 tests. INBS is pursuing FDA clearance for its opiate test system to expand into broader U.S. markets in 2025.
06-11 12:30
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
Intelligent Bio Solutions Inc. (INBS) will collaborate with SMARTOX at RISE25 to showcase its fingerprint drug testing technology. The portable system detects recent drug use within minutes, suitable for justice and treatment settings. RISE25 attracts over 7,000 attendees focused on addiction and justice innovation.
05-22 12:30
Intelligent Bio Solutions Q4 Sales $730.00K Up From $443.13K YoY
Intelligent Bio Solutions (NASDAQ:INBS) reported $730.00 thousand in sales this quarter. This is a 64.74 percent increase over sales of $443.13 thousand the same period last year.
2024-09-19 20:39
Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gai...
2024-09-10 00:04
What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?
Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The company, specializing in non-invasive testing, advances clinical trials and reports significant growth in drug screening system installations.
2024-09-09 22:24
US Stocks Higher; Dow Surges Over 200 Points
U.S. stocks traded higher this morning, with the Dow Jones index gaining more t...
2024-09-09 21:54
Intelligent Bio Solutions Shares Preliminary Q4 Revenue Of $730K; FY24 Revenue Of $3.11M
- 2024 unaudited revenue growth for the fiscal fourth quarter and full year of approximately 64% and 148% year-over-year, respectively -NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions
2024-09-09 20:34
